Tartaric Acid & TARTARIC ACID Excipient Use in Subcutaneous Dosage Forms

Tartaric Acid

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

1 Listed Products, 1 SPI Pharma

REGULATORY FILINGS

5 Suppliers, 5 USDMF

SOLUTIONS BY APPLICATIONS

1 Solubilizers

1 Solubilizers

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

FINISHED FORMULATIONS

33 ORAL, 10 SOLUTION, 8 CAPSULE, 7 INJECTABLE, 7 INJECTION, 7 TABLET, 6 TABLET, EXTENDED RELEASE, 5 CAPSULE, EXTENDED RELEASE, 4 INTRAVENOUS, 4 TOPICAL, 3 PATCH, 2 TABLET, ORALLY DISINTEGRATING, 1 INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, 1 SUBCUTANEOUS, 1 SUSPENSION, EXTENDED RELEASE, 1 SYSTEM